Haiyan Zeng

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trials.

Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trials.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 07, 2024

Investigating esophageal sarcomatoid carcinoma and its comparison with esophageal squamous cell carcinoma on clinicopathological characteristics, prognosis, and radiomics features: a retrospective study.

Investigating esophageal sarcomatoid carcinoma and its comparison with esophageal squamous cell carcinoma on clinicopathological characteristics, prognosis, and radiomics features: a retrospective study.

Journal: Frontiers in oncology

Published: March 11, 2024

Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial.

Association of Serum Biomarkers With Neurocognitive Decline After PCI in Small Cell Lung Cancer: An Exploratory Study of the Phase III NCT01780675 Trial.

Journal: Clinical lung cancer

Published: February 28, 2024

The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer.

The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer.

Journal: Cancers

Published: May 10, 2023

Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675).

Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675).

Journal: JTO clinical and research reports

Published: March 16, 2023

Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study.

Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 16, 2022

Effectivity of involved-field radiotherapy for recurrent brain metastasis in patients with small-cell lung cancer.

Effectivity of involved-field radiotherapy for recurrent brain metastasis in patients with small-cell lung cancer.

Journal: Journal of cancer research and therapeutics

Published: October 07, 2022

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.

Investigation of the added value of CT-based radiomics in predicting the development of brain metastases in patients with radically treated stage III NSCLC.

Journal: Therapeutic advances in medical oncology

Published: March 05, 2022

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Journal: Frontiers in oncology

Published: March 03, 2022

Radiotherapy for small cell lung cancer in current clinical practice guidelines.

Radiotherapy for small cell lung cancer in current clinical practice guidelines.

Journal: Journal of the National Cancer Center

Published: November 29, 2021

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer.

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer.

Journal: Frontiers in oncology

Published: June 26, 2020

Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.

Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review.

Journal: Cancer treatment reviews

Published: February 28, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026